ACAD
38.01
-0.22
-0.58%
AEMD
0.19
0.00
-2.26%
APRI
2.37
-0.16
-6.32%
ARNA
4
-0.28
-6.54%
ATEC
1.49
-0.01
-0.67%
CFN
60.07
-0.13
-0.22%
CNAT
6.31
+0.11
+1.77%
CRXM
0.2
-0.01
-4.72%
CYTX
1.21
+0.09
+8.04%
DXCM
58.5
-1.16
-1.94%
GNMK
12.71
-0.27
-2.08%
HALO
15.11
-0.11
-0.72%
ILMN
195.88
+1.82
+0.94%
INNV
0.19
+0.02
+8.89%
INO
7.02
-0.15
-2.09%
ISCO
0.06
0.00
-1.94%
ISIS
68.19
+1.39
+2.08%
LGND
66.93
+3.35
+5.27%
LPTN
2.98
+0.04
+1.24%
MBVX
0.93
+0.03
+3.33%
MEIP
5.54
-0.12
-2.12%
MNOV
3.6
+0.06
+1.69%
MRTX
23.6
-0.59
-2.44%
MSTX
0.53
0.00
-0.38%
NBIX
40.48
+0.05
+0.12%
NUVA
44.09
-0.58
-1.30%
ONCS
0.37
+0.01
+2.62%
ONVO
5.73
-0.02
-0.35%
OREX
8.01
+2.22
+38.34%
OTIC
35.81
-0.58
-1.58%
QDEL
26.1
-0.31
-1.17%
RCPT
124.91
-2.18
-1.72%
RGLS
18
-0.57
-3.07%
RMD
64.47
-0.3
-0.46%
SCIE
0.03
0.00
0.00%
SPHS
0.7
-0.04
-5.41%
SRNE
12.99
+0.12
+0.93%
TROV
6.21
+0.16
+2.64%
VICL
0.99
+0.00
+0.01%
VOLC
17.99
0.00
0.00%
ZGNX
1.68
-0.02
-0.89%
Home » Archive by Category

Xconomy

It Had to be You: Why Roche Was The Lone Suitor For Foundation

January 16, 2015 – 7:38 am

The buzz from day one of the J.P. Morgan Healthcare Conference in San Francisco earlier this week was the announcement on Sunday night by Roche that it was acquiring a majority interest in Foundation…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More

January 15, 2015 – 5:01 pm

Whew. J.P. Morgan is almost over. (The healthcare conference, that is, not the investment bank.) Opening the week’s proceedings at the Biotech Showcase, a satellite conference that features…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More

January 15, 2015 – 5:01 pm

Whew. J.P. Morgan is almost over. (The healthcare conference, that is, not the investment bank.) Opening the week’s proceedings at the Biotech Showcase, a satellite conference that features…

[[Click headline to continue reading.]]

Qualcomm-Novartis Deal Portends Wave of Clinical Trial Innovation

January 14, 2015 – 11:49 pm

The significance of a deal announced last week during the 2015 International CES in Las Vegas went largely unnoticed amid the hubbub of the world’s biggest consumer technology show, packed as it was…

[[Click headline to continue reading.]]

Houston, Austin, Raleigh, Denver Tops in U.S. for STEM Workers

January 14, 2015 – 8:44 am

All metro areas are not created equal. If you’re looking at job markets in science, technology, engineering, and math (STEM)—a major indicator of economic growth and innovation—the U.S….

[[Click headline to continue reading.]]

In Search of a Better Approach to Breast Cancer Screening

January 14, 2015 – 1:00 am

As a venture investor in the healthcare sector, I see a lot of new medical technologies that promise improvement over the current standard of care. Opportunities that represent truly transformational…

[[Click headline to continue reading.]]

Qualcomm Ventures Forms Joint Investment Business with Novartis

January 12, 2015 – 5:33 pm

Qualcomm (NASDAQ: QCOM), the San Diego wireless technologies giant, plans to form a joint investment business through its corporate ventures arm with the Swiss pharmaceutical giant Novartis. The…

[[Click headline to continue reading.]]

10X Genomics Emerges With $80M and Toaster-Sized Sequencer Upgrade

January 12, 2015 – 6:00 am

Making Illumina’s industry-leading gene sequencing machines better? There’s an app for that. That’s the shorthand pitch from fresh-from-stealth sequencing company 10X Genomics,…

[[Click headline to continue reading.]]

10X Genomics Emerges With $80M and Toaster-Sized Sequencer Upgrade

January 12, 2015 – 6:00 am

Making Illumina’s industry-leading gene sequencing machines better? There’s an app for that. That’s the shorthand pitch from fresh-from-stealth sequencing company 10X Genomics,…

[[Click headline to continue reading.]]

Genentech Redux? Roche Buys Majority Stake in Foundation Medicine

January 11, 2015 – 11:00 pm

In a deal that shakes up the full-steam-ahead world of cancer diagnostics, the world’s top oncology drug company, Roche, said today it’s spending more than $1 billion for a majority stake in…

[[Click headline to continue reading.]]